ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

3 Value Stocks Walking a Fine Line

SJM Cover Image

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. That said, here are three value stocks with poor fundamentals and some alternatives you should consider instead.

J. M. Smucker (SJM)

Forward P/E Ratio: 11x

Best known for its fruit jams and spreads, J.M Smucker (NYSE: SJM) is a packaged foods company whose products span from peanut butter and coffee to pet food.

Why Are We Cautious About SJM?

  1. Muted 3.7% annual revenue growth over the last three years shows its demand lagged behind its consumer staples peers
  2. Sales are projected to remain flat over the next 12 months as demand decelerates from its three-year trend
  3. Low returns on capital reflect management’s struggle to allocate funds effectively, and its falling returns suggest its earlier profit pools are drying up

J. M. Smucker’s stock price of $111.49 implies a valuation ratio of 11x forward price-to-earnings. Dive into our free research report to see why there are better opportunities than SJM.

Nu Skin (NUS)

Forward P/E Ratio: 7.6x

With person-to-person marketing and sales rather than selling through retail stores, Nu Skin (NYSE: NUS) is a personal care and dietary supplements company that engages in direct selling.

Why Do We Avoid NUS?

  1. Annual revenue declines of 13.7% over the last three years indicate problems with its market positioning
  2. Overall productivity fell over the last year as its plummeting sales were accompanied by a decline in its operating margin
  3. Sales were less profitable over the last three years as its earnings per share fell by 41.2% annually, worse than its revenue declines

Nu Skin is trading at $8.20 per share, or 7.6x forward price-to-earnings. Read our free research report to see why you should think twice about including NUS in your portfolio.

MasterCraft (MCFT)

Forward P/E Ratio: 15.6x

Started by a waterskiing instructor, MasterCraft (NASDAQ: MCFT) specializes in designing, manufacturing, and selling sport boats.

Why Are We Wary of MCFT?

  1. Sluggish trends in its boats sold suggest customers aren’t adopting its solutions as quickly as the company hoped
  2. Projected sales growth of 7.2% for the next 12 months suggests sluggish demand
  3. Performance over the past five years shows each sale was less profitable as its earnings per share dropped by 26.6% annually, worse than its revenue

At $17.96 per share, MasterCraft trades at 15.6x forward price-to-earnings. If you’re considering MCFT for your portfolio, see our FREE research report to learn more.

Stocks We Like More

The Trump trade may have passed, but rates are still dropping and inflation is still cooling. Opportunities are ripe for those ready to act - and we’re here to help you pick them.

Get started by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.

Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Comfort Systems (+751% five-year return). Find your next big winner with StockStory today for free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.